Clinical Trials for Mesothelin-positive Advanced Malignant Solid Tumors

Find clinical trials for mesothelin-positive advanced malignant solid tumors. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

CT-95 in Advanced Cancers Associated With Mesothelin Expression

NCT ID: NCT06756035

This clinical trial is studying a new treatment called CT-95 for patients with advanced cancers that express a protein called mesothelin. Mesothelin is found in certain types of tumors, including a...

Recruiting

Phase: PHASE1 Type: interventional Locations: San Antonio, Texas, United States, Hackensack, New Jersey, United States +5 more

Anti-Mesothelin CAR-T Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

NCT ID: NCT07010523

This clinical trial is testing a new treatment called Anti-Mesothelin CAR-T cell injection for patients with advanced malignant solid tumors that are positive for a protein called mesothelin. The g...

Recruiting

Phase: NA Type: interventional Locations: Hangzhou, , China

MSLN-targeted CAR-T Cells in Solid Tumors.

NCT ID: NCT05783089

This clinical trial is studying a new treatment called Anti-Mesothelin CAR-T cells for patients with advanced solid tumors that test positive for a protein called mesothelin. The main goals are to ...

Not yet recruiting

Phase: PHASE1 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions